Phenotype
|
Fish
|
Conditions
|
Figures
|
hypophysis male organism fshb expression increased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
ovary decreased size, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
ovarian follicle stage I increased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
male sex differentiation process quality, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 3
from Zhang et al., 2020
|
ovary increased size, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 3
from Zhang et al., 2020
|
female organism female sterile, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
hypophysis male organism fshb expression decreased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 5
from Zhang et al., 2020
|
female mating behavior decreased occurrence, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
spermatogonium increased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 3
from Zhang et al., 2020
|
testis inha expression increased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
sperm decreased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 3
from Zhang et al., 2020
|
spermatocyte decreased amount, abnormal
|
amhumo17/umo17
|
standard conditions
|
Fig. 3
from Zhang et al., 2020
|
hypophysis female organism fshb expression increased amount, abnormal
|
amhumo17/+; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
hypophysis male organism fshb expression decreased amount, abnormal
|
amhumo17/umo17; inhaumo19/+
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
hypophysis female organism fshb expression decreased amount, abnormal
|
amhumo17/umo17; inhaumo19/+
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
testis increased size, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
ovarian follicle stage I increased amount, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
ovary increased size, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
ovarian follicle stage II increased amount, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
spermatogonium increased amount, abnormal
|
amhumo17/umo17; inhaumo19/umo19
|
standard conditions
|
Fig. 6
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
bmpr2aumo25/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
ovary accumulation ovarian follicle stage I, abnormal
|
bmpr2aumo25/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
hypophysis fshb expression decreased amount, abnormal
|
bmpr2aumo25/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis accumulation spermatogonium, abnormal
|
bmpr2aumo25/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
male organism gonad increased weight, abnormal
|
bmpr2aumo25/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
bmpr2aumo25/umo25; amhumo17/+ (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
ovary accumulation ovarian follicle stage I, abnormal
|
bmpr2aumo25/umo25; amhumo17/+ (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
hypophysis fshb expression decreased amount, abnormal
|
bmpr2aumo25/umo25; amhumo17/+ (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis accumulation spermatogonium, abnormal
|
bmpr2aumo25/umo25; amhumo17/+ (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
male organism gonad increased weight, abnormal
|
bmpr2aumo25/umo25; amhumo17/+ (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
hypophysis fshb expression decreased amount, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
ovary accumulation ovarian follicle stage I, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis accumulation spermatogonium, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
whole organism semi-fertile, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
male organism gonad increased weight, abnormal
|
bmpr2aumo25/umo25; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 4
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
fshbumo1/+; amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
spermatogenesis process quality, abnormal
|
fshbumo1/+; amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
testis increased area, abnormal
|
fshbumo1/+; amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
ovary gamete generation disrupted, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis cell population proliferation increased process quality, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
ovary cell population proliferation increased process quality, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
ovary oocyte differentiation decreased process quality, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
gonad hypertrophic, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis spermatid differentiation decreased process quality, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis gamete generation disrupted, abnormal
|
fshbumo1/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
female organism developmental process involved in reproduction delayed, abnormal
|
fshbumo1/umo1; amhumo17/+
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
female organism follicle cell of egg chamber development delayed, abnormal
|
fshbumo1/umo1; amhumo17/+
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
spermatogenesis delayed, abnormal
|
fshbumo1/umo1; amhumo17/+
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
testis hypotrophic, abnormal
|
fshbumo1/umo1; amhumo17/+
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
female organism developmental process involved in reproduction delayed, abnormal
|
fshbumo1/umo1; amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
female organism follicle cell of egg chamber development delayed, abnormal
|
fshbumo1/umo1; amhumo17/umo17
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
ovary gamete generation disrupted, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis cell population proliferation increased process quality, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
ovary cell population proliferation increased process quality, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
ovary oocyte differentiation decreased process quality, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
gonad hypertrophic, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis gamete generation disrupted, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
testis spermatid differentiation decreased process quality, abnormal
|
fshbumo1/umo1; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 1
from Zhang et al., 2020
|
ovary hypertrophic, abnormal
|
fshrumo3/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovary accumulation ovarian follicle stage I, abnormal
|
fshrumo3/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovary hypotrophic, abnormal
|
fshrumo3/umo3; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovarian follicle stage I immature, abnormal
|
fshrumo3/umo3; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovarian follicle stage I decreased amount, abnormal
|
fshrumo3/umo3; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
male organism increased amount, abnormal
|
fshrumo3/umo3; amhumo17/umo17
|
standard conditions
|
Fig. 10
from Zhang et al., 2020
|
sex differentiation process quality, abnormal
|
fshrumo3/umo3; amhumo17/umo17
|
standard conditions
|
Fig. 10
from Zhang et al., 2020
|
ovary hypotrophic, abnormal
|
fshrumo3/umo3; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovarian follicle stage I immature, abnormal
|
fshrumo3/umo3; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovarian follicle stage I decreased amount, abnormal
|
fshrumo3/umo3; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
gdf9umo18/+; amhumo17/umo17
|
standard conditions
|
Fig. 8
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
gdf9umo18/umo18; amhumo17/umo17
|
standard conditions
|
Fig. 8
from Zhang et al., 2020
|
ovary increased size, abnormal
|
gdf9umo18/umo18; amhumo17/umo17
|
standard conditions
|
Fig. 8
from Zhang et al., 2020
|
ovary increased size, abnormal
|
fshbumo1/+; gdf9umo18/umo18; amhumo17/umo17
|
standard conditions
|
Fig. 9
from Zhang et al., 2020
|
ovary decreased size, abnormal
|
fshbumo1/umo1; gdf9umo18/umo18; amhumo17/umo17
|
standard conditions
|
Fig. 9
from Zhang et al., 2020
|
testis hypertrophic, abnormal
|
fshrumo3/+; lhcgrumo4/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis meiosis I decreased process quality, abnormal
|
fshrumo3/+; lhcgrumo4/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis spermatogenesis disrupted, abnormal
|
fshrumo3/+; lhcgrumo4/+; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis meiosis I disrupted, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis spermatogenesis disrupted, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis hypotrophic, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/+ (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
ovarian follicle stage I developmental cell growth arrested, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis meiosis I disrupted, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis hypotrophic, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|
testis spermatogenesis disrupted, abnormal
|
fshrumo3/umo3; lhcgrumo4/umo4; amhumo17/umo17 (AB)
|
standard conditions
|
Fig. 2
from Zhang et al., 2020
|